Mary Gessner-Peterson, DO
Emergency Medical Services · Alpine, CANPI 1861662884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Johnson & Johnson at 47.8% of the total. Reporting peaked in 2019 at $130 and has fallen 84.9% since, to $20 in 2024.
Across 14 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$118
- Lilly USA, LLC$85
- Philips North America LLC$17
- Sun Pharmaceutical Industries Inc.$16
- Shire North American Group Inc$12
What the payments were for
- Food & beverage$248100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $118 |
| Lilly USA, LLC | 3 | $85 |
| Philips North America LLC | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$248 in reported general payments places this provider in the 60th percentile of 103 emergency medical services providers in California.
See all emergency medical services providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 939 | $342,508 |
| XareltoRivaroxaban | 446 | $158,176 |
| Austedo XrDeutetrabenazine | 47 | $155,021 |
| OzempicSemaglutide | 133 | $135,225 |
| IngrezzaValbenazine Tosylate | 16 | $112,600 |
| Breo ElliptaFluticasone/Vilanterol | 244 | $100,852 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 145 | $100,005 |
| TrulicityDulaglutide | 112 | $97,777 |
| Invega SustennaPaliperidone Palmitate | 25 | $82,552 |
| JardianceEmpagliflozin | 188 | $72,328 |
| JanuviaSitagliptin Phosphate | 166 | $71,662 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 17 | $67,706 |
| MyrbetriqMirabegron | 152 | $52,932 |
| EntrestoSacubitril/Valsartan | 142 | $52,650 |
| RexultiBrexpiprazole | 35 | $48,565 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto, Invega Sustenna | $118 | $240,728471 claims |
| Lilly USA, LLCTrulicity | $85 | $97,777112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 103 emergency medical services providers in California.
Other emergency medical services in Alpine
- Griffeth TullyMountain View$114K
- Nathan GilmoreDana Point$90K
- Leonard SchulkindSan Diego$29K
- William MowerLos Angeles$12K
- Diku MandaviaWest Hollywood$9K
- Maria RavenSan Francisco$6K
- James EliaColton$4K
- Kelly PainterWest Hollywood$3K
- Oghogho UhunmwanghoClovis$2K
- Brian MiuraTorrance$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.